Related references
Note: Only part of the references are listed.Immunohistochemical Staining in the Assessment of Melanoma Tumor Thickness
Kambiz Kamyab-Hesary et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway
David E. Elder et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)
Immunohistochemical detectability of cyclooxygenase-2 expression in cells of human melanocytic skin lesions: A methodological review
Lukasz Kuzbicki et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2020)
Drawing Guidelines for Receiver Operating Characteristic Curve in Preparation of Manuscripts
Jeehyoung Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Expression of Glut-1 in Malignant Melanoma and Melanocytic Nevi: an Immunohistochemical Study of 400 Cases
Miroslav Dura et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
A Practical Approach to the Diagnosis of Melanocytic Lesions
Nathan T. Harvey et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)
Melanoma coexisting with solar elastosis: a potential pitfall in the differential diagnosis between nevus and melanoma
Jonathan C. Konopinski et al.
HUMAN PATHOLOGY (2019)
Current state of melanoma diagnosis and treatment
Lauren E. Davis et al.
CANCER BIOLOGY & THERAPY (2019)
RECEIVER OPERATING CHARACTERISTIC ANALYSIS OF INTRAOPERATIVE PARATHYROID HORMONE MONITORING TO DETERMINE OPTIMUM SENSITIVITY AND SPECIFICITY: ANALYSIS OF 896 CASES
Christina S. Foley et al.
ENDOCRINE PRACTICE (2019)
Expression of p15 in a spectrum of spitzoid melanocytic neoplasms
Sophia A. Ma et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2019)
Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions
Michael W. Piepkorn et al.
JAMA NETWORK OPEN (2019)
A quantitative comparison between SOX10 and MART-1 immunostaining to detect melanocytic hyperplasia in chronically sun-damaged skin
Sonal Muzumdar et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2018)
Enhanced intratumoral expression of RNF2 is a favorable prognostic factor for patients with cutaneous melanoma?
Łukasz Kuźbicki et al.
Oncotarget (2018)
PRAME Expression in Melanocytic Tumors
Cecilia Lezcano et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Histopathologic features of melanoma in difficult-to-diagnose lesions: A case-control study
Manuel Lora Gonzalez et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study
Joann G. Elmore et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study
Joann G. Elmore et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Intratumoral expression of cyclooxygenase-2 (COX-2) is a negative prognostic marker for patients with cutaneous melanoma
Lukasz Kuzbicki et al.
MELANOMA RESEARCH (2016)
ROC-ing along: Evaluation and interpretation of receiver operating characteristic curves
Jane V. Carter et al.
SURGERY (2016)
Melan-A positive dermal cells in malignant melanoma in situ
Mary Elizabeth Danga et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2015)
Automated quantification of MART1-verified Ki-67 indices: useful diagnostic aid in melanocytic lesions
Patricia Switten Nielsen et al.
HUMAN PATHOLOGY (2014)
5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi
Ryuhei Uchiyama et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2014)
Immunohistochemical expression of p16 in desmoplastic melanoma
Elena Blokhin et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2013)
Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma
Thilo Gambichler et al.
MELANOMA RESEARCH (2013)
Pitfalls in the evaluation of melanocytic lesions
Thomas Brenn
HISTOPATHOLOGY (2012)
The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions
Lukasz Kuzbicki et al.
MELANOMA RESEARCH (2012)
Novel Multiple Markers to Distinguish Melanoma from Dysplastic Nevi
Guohong Zhang et al.
PLOS ONE (2012)
Receiver Operating Characteristic (ROC) Curve for Medical Researchers
Rajeev Kumar et al.
INDIAN PEDIATRICS (2011)
p16 Expression: A marker of differentiation between childhood malignant melanomas and Spitz nevi
Rola Al Dhaybi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
BRG1 expression is increased in human cutaneous melanoma
H. Lin et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
IMP-3 expression in melanocytic lesions
Limin Yu et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2010)
Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center
B. Aika Shoo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Receiver Operating Characteristic Curve in Diagnostic Test Assessment
Jayawant N. Mandrekar
JOURNAL OF THORACIC ONCOLOGY (2010)
WT1 marker is not sufficient for distinguishing between melanoma and melanocytic nevi
Karli Rosner et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2009)
Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi
Loren E. Clarke et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2009)
Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting
Saurabh Lodha et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2008)
Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions
Paola Parente et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions
Bonnie E. Gould Rothberg et al.
MODERN PATHOLOGY (2008)
IMP-3 is a novel progression marker in malignant melanoma
Jennifer G. Pryor et al.
MODERN PATHOLOGY (2008)
Skin layer-specific Melan-A expression during progression of human cutaneous melanoma: implications for diagnostic applications of the marker
Anna Sztramska et al.
MELANOMA RESEARCH (2008)
Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma
Amira Sanki et al.
PATHOLOGY (2007)
WT1 as a complementary marker of malignant melanoma: an immunohistochemical study of whole sections
M. Wilsher et al.
HISTOPATHOLOGY (2007)
Expression of polycomb group protein EZH2 in nevi and melanoma
Jonathan B. McHugh et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
Expression of activated Akt in benign nevi, Spitz nevi and melanomas
Sara M. Kantrow et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
Differentiating spitzoid melanomas from Spitz nevi through CD99 expression
Mark S. King et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
Cyclooxygenase-2 (COX-2): first immunohistochernical marker distinguishing early cutaneous melanomas from benign melanocytic skin turnours
Barbara W. Chwirot et al.
MELANOMA RESEARCH (2007)
Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma
K. A. Giehl et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma
A. R. Shors et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Expression of c-kit (CD117) in Spitz nevus and malignant melanoma
YI Zhu et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2006)
Molecular diagnostics in melanoma
JA Carlson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Reliability of diagnosis of melanoma in situ
M Megahed et al.
LANCET (2002)
Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions
L Brochez et al.
JOURNAL OF PATHOLOGY (2002)
Share Paper
